WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aprea Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Oren GiladPresidentCEO2026-01-3028,100$0.89
$25.01kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2026-01-305,700$0.89
$5.07kBuy
Marc DueyDirector2025-12-1021,459$1.17
$25.00kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2025-12-105,000$1.17
$5.83kBuy
Oren GiladPresidentCEO2025-04-033,003$1.87
$5.62kBuy
Oren GiladPresidentCEO2025-04-032,497$1.80
$4.49kBuy

1 of 1

APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APRE insiders and whales buy or sell their stock.

APRE Shareholders

What type of owners hold Aprea Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tryant LLC244.49%28,000,000$20.47MInsider
Thomas Banks116.93%13,391,146$9.79MInsider
Frank J. Hall41.75%4,781,889$3.50MInsider
David West Wilson25.54%2,924,726$2.14MInsider
Heidi A. Patterson23.47%2,688,221$1.97MInsider
Kdev Investments Ab17.40%1,992,586$1.46MInsider
Michael Reynolds17.29%1,980,040$1.45MInsider
Redmile Group LLC15.44%1,768,718$1.29MInsider
Oren Gilad3.46%395,695$289.25kInsider
Aigh Capital Management LLC3.24%370,541$270.87kInstitution

1 of 3

APRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APRE2.77%97.23%Net BuyingNet Buying
BOLT2.93%97.07%Net Buying
RNAZ0.11%99.89%
TOVX2.82%0.54%
ITRM3.16%43.21%Net Buying
View Top Biotech Stocks

Aprea Therapeutics Stock Ownership FAQ

Who owns Aprea Therapeutics?

Aprea Therapeutics (NASDAQ: APRE) is owned by 14.80% institutional shareholders, 519.40% Aprea Therapeutics insiders, and 0.00% retail investors. Tryant LLC is the largest individual Aprea Therapeutics shareholder, owning 28.00M shares representing 244.49% of the company. Tryant LLC's Aprea Therapeutics shares are currently valued at $21.36M.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.